top of page

Videnskabelige studier om mRNA

Acute Myocarditis After COVID-19 Vaccination 1

Cardiac

Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection

Cardiac

Acute Myocarditis after COVID-19 vaccination, A case report

Cardiac

Acute myocarditis after COVID-19 vaccination

Cardiac

Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccin

Cardiac

Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man

Cardiac

Acute myocarditis after the second dose of SARS-CoV-2 vaccine, Serendipity or atypical causal relationship

Cardiac

Acute myocarditis after the third dose of COVID-19 mRNA-1273 vaccine

Cardiac

Acute myocarditis associated with anti-COVID-19 vaccination

Cardiac

Acute myocarditis associated with COVID-19 vaccination, A case report

Cardiac

Acute myocarditis associated with the Pfizer BioNTech vaccine

Cardiac

Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination

Cardiac

Acute myocarditis following administration of BNT162b2 vaccine

Cardiac

Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection

Cardiac

Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021

Allergic

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021

Allergic

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts

Allergic

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

Allergic

Severe nonanaphylactic allergic reaction to the Pfizer-BioNTech COVID-19 vaccine

Allergic

Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines

Allergic
bottom of page